Chembio Diagnostics (CEMI), Bio-Manguinhos/Fiocruz to Develop Point-of-Care Zika Diagnostic Tests for Brazil
Tweet Send to a Friend
Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced plans to collaborate ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
